v3.25.4
Income Taxes
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes

16. Income Taxes

Income (loss) before provision for income taxes was as follows:

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

United States

 

$

9,496

 

 

$

(34,540

)

 

$

(211,528

)

Foreign

 

 

59,967

 

 

 

63,217

 

 

 

60,953

 

Total

 

$

69,463

 

 

$

28,677

 

 

$

(150,575

)

The provision for income taxes consists of the following:

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Current income tax expense

 

 

 

 

 

 

 

 

 

Federal

 

$

(4,348

)

 

$

(7,631

)

 

$

(1,162

)

State

 

 

(1,406

)

 

 

(1,640

)

 

 

(803

)

Foreign

 

 

(17,800

)

 

 

(12,088

)

 

 

(11,420

)

Total current income tax expense

 

 

(23,554

)

 

$

(21,359

)

 

$

(13,385

)

Deferred income tax (expense) benefit

 

 

 

 

 

 

 

 

 

Federal

 

 

(829

)

 

 

(337

)

 

 

 

State

 

 

(777

)

 

 

(47

)

 

 

 

Foreign

 

 

1,608

 

 

 

(2,306

)

 

 

(550

)

Total deferred income tax benefit (expense)

 

 

2

 

 

 

(2,690

)

 

$

(550

)

Total income tax expense

 

$

(23,552

)

 

$

(24,049

)

 

$

(13,935

)

 

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

 

(in thousands)

 

Net income taxes paid

 

 

 

Federal

 

$

2,407

 

State

 

 

2,493

 

Australia

 

 

2,392

 

Belgium

 

 

1,793

 

Colombia

 

 

1,323

 

France

 

 

1,631

 

Germany

 

 

2,696

 

Japan

 

 

1,653

 

United Kingdom

 

 

1,347

 

Other foreign

 

 

1,576

 

Total income taxes paid (net of refunds received)

 

$

19,311

 

 

 

 

 

 

The following reconciles the differences between income taxes computed at the federal statutory rate of 21% and the provision for income taxes for 2025:

 

 

 

Year Ended December 31, 2025

 

 

 

(in thousands)

 

%

 

U.S. Federal statutory tax rate

 

$

(14,588

)

 

(21

%)

U.S. State and local income tax, net of federal (national) income tax effect (1)

 

 

1,082

 

 

2

 

Foreign tax effects

 

 

 

 

 

Brazil

 

 

(1,145

)

 

(2

)

Canada

 

 

(1,690

)

 

(2

)

Colombia

 

 

(888

)

 

(1

)

France

 

 

(1,569

)

 

(2

)

Germany

 

 

(1,046

)

 

(2

)

Ireland

 

 

 

 

 

Statutory tax rate difference between Ireland and United States

 

 

1,830

 

 

3

 

Non-taxable items

 

 

2,580

 

 

4

 

Other

 

 

(188

)

 

(0

)

Singapore

 

 

(866

)

 

(1

)

United Kingdom

 

 

(1,172

)

 

(2

)

Other foreign jurisdictions

 

 

(2,866

)

 

(4

)

Effect of cross-border tax laws

 

 

 

 

 

Foreign tax credits

 

 

2,996

 

 

4

 

Tax credits

 

 

 

 

 

Research and development credits

 

 

41,859

 

 

60

 

Changes in valuation allowances

 

 

(37,148

)

 

(53

)

Non-taxable or non-deductible items

 

 

 

 

 

Executive compensation limit

 

 

(8,263

)

 

(12

)

Stock-based compensation

 

 

15,240

 

 

22

 

Transaction costs

 

 

(5,332

)

 

(8

)

Other

 

 

(1,184

)

 

(2

)

Changes in unrecognized tax benefits

 

 

(12,554

)

 

(18

)

Other adjustments

 

 

1,360

 

 

2

 

Effective tax rate

 

$

(23,552

)

 

(34

%)

(1) State taxes in Pennsylvania, New York, New Hampshire, New York City, and Texas made up the majority (greater than 50%) of the tax effect in this category.

 

The following reconciles the differences between income taxes computed at the federal statutory rate of 21% and the provision for income taxes for 2024 and 2023:

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

(in thousands)

 

Expected income tax (expense) benefit at the federal statutory rate

 

$

(6,123

)

 

$

37,845

 

State taxes net of federal benefit

 

 

732

 

 

 

9,131

 

Stock-based compensation

 

 

31,010

 

 

 

7,741

 

Executive compensation limitation

 

 

(10,511

)

 

 

(4,151

)

Difference in foreign tax rates

 

 

(2,499

)

 

 

(2,614

)

Non-deductible acquisition costs

 

 

(1,447

)

 

 

 

U.S. tax credits

 

 

63,124

 

 

 

45,274

 

Foreign withholding taxes

 

 

(2,044

)

 

 

(1,449

)

Change in valuation allowance

 

 

(99,229

)

 

 

(105,181

)

Non research and development tax reserves

 

 

(4,276

)

 

 

 

Foreign derived intangible income

 

 

4,872

 

 

 

 

Other U.S. and foreign permanent differences

 

 

2,342

 

 

 

(531

)

Income tax expense

 

$

(24,049

)

 

$

(13,935

)

Deferred Tax Assets and Liabilities — Deferred income taxes reflect the net effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities were as follows:

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

 

(in thousands)

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

285,126

 

 

$

178,424

 

Research and investment credits

 

 

224,226

 

 

 

181,411

 

Accruals and reserves

 

 

32,170

 

 

 

25,148

 

Lease liability

 

 

47,711

 

 

 

54,028

 

Depreciation

 

 

1,454

 

 

 

552

 

Capitalized software development

 

 

185,582

 

 

 

277,932

 

Stock-based compensation

 

 

27,977

 

 

 

23,145

 

Other assets

 

 

3,992

 

 

 

 

Total deferred tax assets

 

 

808,238

 

 

 

740,640

 

Deferred tax liabilities:

 

 

 

 

 

 

Intangible assets

 

 

(5,856

)

 

 

(6,635

)

Convertible debt

 

 

 

 

 

(56

)

Capitalized costs

 

 

(69,778

)

 

 

(51,150

)

Right of use assets

 

 

(35,839

)

 

 

(38,871

)

Depreciation

 

 

(1,365

)

 

 

(1,276

)

Other liabilities

 

 

(5,325

)

 

 

(7,446

)

Total deferred tax liabilities

 

 

(118,163

)

 

 

(105,434

)

Valuation allowance

 

 

(694,085

)

 

 

(637,609

)

Net deferred tax liabilities

 

$

(4,010

)

 

$

(2,403

)

The Company reviews all available evidence to evaluate the realizability of its deferred tax assets, including its recent history of accumulated losses over the most recent three years as well as its ability to generate income in future periods. The Company has provided a valuation allowance against its U.S. net deferred tax assets as it is more likely than not that these assets will not be realized given the nature of the assets and the likelihood of future utilization.

The valuation allowance increased by $56.5 million in 2025, $101.3 million in 2024 and $127.5 million in 2023.

 

The following summarizes activity related to valuation allowances on deferred tax assets:

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Valuation allowance—beginning of the year

 

$

637,609

 

 

$

536,311

 

 

$

408,794

 

Changes to existing valuation allowances—additions to costs
   and expenses

 

 

50,249

 

 

 

99,229

 

 

 

105,181

 

Changes to existing valuation allowances—additions to other
   accounts (primarily goodwill)

 

 

6,227

 

 

 

2,069

 

 

 

22,336

 

Valuation allowance—end of period

 

$

694,085

 

 

$

637,609

 

 

$

536,311

 

The Company will continue to maintain a full valuation allowance on its deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of this allowance. However, given the anticipated future earnings of the Company, management believes that there is a reasonable possibility that within the next 12 months, sufficient positive evidence may become available to reach a conclusion that all or a portion of the valuation allowance may no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. The exact timing and amount of the valuation allowance release are subject to change on the basis of the level of profitability that the Company is able to actually achieve.

The Company had federal and state net operating loss carryforwards of $1.1 billion and $866.1 million at December 31, 2025 and $640.0 million and $723.7 million at December 31, 2024. The Company also had international net operating loss carryforwards of $0.7 million at December 31, 2025 and $0.9 million at December 31, 2024. All federal net operating losses have an indefinite carryforward period. State net operating losses will begin to expire in 2027.

The Company has net federal research and development credit carryforwards of $198.0 million at December 31, 2025 that begin to expire in 2034. The Company also has state research and investment tax credit carryforwards of $91.5 million that begin to expire in 2026.

Under Section 382 of the Internal Revenue Code of 1986, as amended, substantial changes in the Company's ownership may limit the amount of net operating loss carryforwards that could be utilized annually in the future to offset taxable income. Specifically, this limitation may arise in the event of a cumulative change in ownership of the Company of more than 50% within a three-year period. Any such annual limitation may significantly reduce the utilization of net operating loss carryforwards before they expire.

Uncertain Tax Positions — The Company accounts for uncertainty in income taxes using a two-step process. The Company first determines whether it is more likely than not that a tax position will be sustained upon examination by a tax authority, including resolutions of any related appeals or litigation processes, based on technical merit. If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine the amount of benefit to recognize in the financial statements. The tax position is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.

The following summarizes activity related to unrecognized tax benefits:

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Unrecognized benefit—beginning of the year

 

$

38,327

 

 

$

20,469

 

 

$

16,888

 

Gross increases—current period positions

 

 

14,239

 

 

 

13,974

 

 

 

8,071

 

Gross increases—current period business acquisitions

 

 

 

 

 

 

 

 

1,381

 

Gross increase (decrease)—prior period positions

 

 

612

 

 

 

3,884

 

 

 

(5,871

)

Unrecognized benefit—end of period

 

$

53,178

 

 

$

38,327

 

 

$

20,469

 

The majority of the gross unrecognized tax benefits represent a reduction to the research and development tax credit carryforward. The majority of the unrecognized tax benefits decrease deferred tax assets with a corresponding decrease to the valuation allowance.

The Company has elected to recognize interest and penalties related to uncertain tax positions as a component of income tax expense. Interest and penalties recognized during the year and cumulatively have been immaterial.

The Company files tax returns in the United States and various jurisdictions throughout the world where the Company has operations or has established a taxable presence. All of the Company’s tax years remain open to examination in the United States, as carryforward attributes generated in past years may still be adjusted upon examination by the Internal Revenue Service or state tax authorities if they have or will be used in future periods. The Company is no longer subject to examination for years prior to 2019 in various significant tax jurisdictions and continues to be routinely examined by various taxing authorities.